The global Circular Dichroism Spectrometers Market size was estimated at USD 38.27 million in 2025 and is expected to reach USD 58 million by 2032, growing at a CAGR of 6.1% from 2025 to 2032. Demand is primarily driven by expanded use of structural characterization workflows in biologics development, where circular dichroism spectroscopy supports rapid assessment of higher-order structure and stability. Strong momentum in Asia Pacific, alongside steady replacement and upgrade cycles in mature research markets, continues to support broader adoption across pharma, CROs, and academic core facilities.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2024
Base Year
2025
Forecast Period
2026-2032
Circular Dichroism Spectrometers Market Size 2025
USD 38.27 million
Circular Dichroism Spectrometers Market, CAGR
6.1%
Circular Dichroism Spectrometers Market Size 2032
USD 58 million
Key Market Trends & Insights
North America accounted for 36.70% of market revenue in 2025, reflecting a large installed base of regulated analytical labs and established biopharma R&D ecosystems.
Asia Pacific represented 29.40% share in 2025, supported by expanding biologics and biosimilars development capacity and rising investments in analytical instrumentation.
Europe held 22.90% share in 2025, underpinned by strong academic research infrastructure and sustained pharmaceutical manufacturing and R&D activity.
Benchtop systems accounted for the largest share of 41.60% in 2025, supported by routine protein folding, stability, and comparability workflows in high-throughput laboratories.
Protein Secondary Structure Analysis captured 22.80% share in 2025, reflecting the continued role of secondary-structure confirmation in formulation, process development, and comparability studies.
Segment Analysis
Circular dichroism spectrometers are increasingly positioned as fast, sample-efficient tools for structural and conformational assessment, particularly in protein characterization and chiral analysis workflows. Procurement decisions are shaped by instrument sensitivity, wavelength range coverage, and ease of use in routine lab operations, with growing attention to software-driven spectral processing and documentation readiness for regulated environments. Laboratories also evaluate vendor service support, calibration practices, and application training as part of total cost and lifecycle risk management.
End-user purchasing behavior reflects a split between asset ownership in high-volume pharma and biotech laboratories and shared-use models in academic facilities and CROs. Research institutes tend to prioritize flexibility and multi-user throughput, whereas commercial labs focus on validated workflows, reproducibility, and integration into existing analytical quality systems. As drug discovery pipelines broaden and biologics characterization requirements become more stringent, CD systems are increasingly selected as part of multi-technique characterization stacks alongside complementary methods.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Benchtop accounted for the largest share of 41.60% in 2025. Benchtop configurations are widely adopted because they fit routine laboratory workflows for protein folding, thermal stability, and secondary-structure estimation without requiring complex facility modifications. These systems are also preferred for daily analytical use due to easier maintenance and faster setup for multiple runs. Demand remains supported by upgrades that enhance signal quality, automation readiness, and usability for high-throughput characterization.
By Product Insights
Light-source configurations influence measurement sensitivity, spectral range, and compatibility with diverse sample types, which directly affects purchase specifications. Laboratories often prefer platforms that balance stability and reproducibility with practical operating requirements for routine use. Multi-source approaches are increasingly evaluated where users need flexibility across protein, nucleic acid, and chiral compound workflows. Selection is also influenced by serviceability, component availability, and long-term performance consistency under frequent use.
By Application Insights
Protein Secondary Structure Analysis accounted for the largest share of 22.80% in 2025. The application leads because CD offers rapid insights into protein conformation and folding changes across pH, temperature, and formulation conditions. It is frequently used to support comparability assessments and stability monitoring where structural shifts need early detection. Continued growth in biologics, biosimilars, and protein engineering reinforces recurring demand for protein-structure-focused CD workflows.
By End User Insights
Pharmaceutical & Biotechnology Companies accounted for the largest share of 39.70% in 2025. This segment leads due to sustained investment in biologics development, formulation, and analytics infrastructure that requires structural characterization tools. Commercial labs also value instrument platforms that support documentation and repeatability needs across multi-stage development pipelines. Contract Research Organizations (CROs) are expanding faster as outsourced analytical characterization demand increases and sponsors seek flexible capacity for development timelines.
Circular Dichroism Spectrometers Market Drivers
Expansion of biologics and biosimilars characterization needs
Biologics development requires reliable tools for tracking conformational integrity across development stages. Circular dichroism supports rapid secondary-structure and stability assessment, enabling earlier detection of structural drift. Biosimilar programs also increase the need for comparability packages using multiple orthogonal methods. This expands routine use of CD systems in both internal labs and outsourced testing environments.
For instance, Applied Photophysics states that its Chirascan Q100 can deliver up to 4 x 96 individual runs with additional microplates and can complete a minimum of 48 buffer-sample pairs in 24 hours, supporting statistically validated higher-order-structure comparisons for biosimilar and degradation studies.
Greater emphasis on stability and formulation screening
Protein therapeutics are sensitive to formulation conditions and environmental stress, raising demand for fast screening tools. CD enables monitoring of structural response to excipients, pH changes, and thermal cycling with low sample consumption. These workflows support faster down-selection of candidate formulations before more complex testing. As development timelines tighten, faster screening utility becomes increasingly valuable.
Growth in outsourcing and shared analytical infrastructure
Sponsors increasingly rely on CROs and shared analytical labs to scale capacity and manage costs. CD systems are well-suited to multi-client usage models because they can be deployed across diverse projects with standardized protocols. Centralized facilities also justify investment in higher-performance configurations due to higher utilization. This supports broader installed base growth outside traditional pharma ownership models.
For instance, JASCO’s Spectra Manager CFR software supports 21 CFR Part 11 compliance with three levels of electronic signatures creation, review, and approval and records an audit trail in each data file, which is highly relevant for shared analytical environments handling regulated, multi-client workflows.
Technology improvements in usability and workflow integration
Instrument and software enhancements improve data quality, reduce operator variability, and simplify routine analysis. Automated sampling, improved detectors, and streamlined spectral processing strengthen throughput and reproducibility. Better integration with laboratory documentation practices supports operational consistency in regulated settings. These advances lower barriers for newer users and improve return on investment for experienced labs.
High upfront instrument costs and ongoing maintenance considerations can limit adoption for smaller laboratories, especially where utilization is uncertain. Operating requirements such as calibration routines, component replacement, and environmental control planning increase total lifecycle effort. Procurement teams also weigh vendor service responsiveness and uptime performance when comparing platforms. These factors can slow purchasing decisions and encourage reliance on shared facilities.
For instance, Thermo Fisher Scientific reported that a review of 38,460 instrument service records across analytical platforms found systems covered by preventive maintenance contracts had fewer repair events and nearly one day less downtime per year on average than reactive-only service models, underscoring how service quality and maintenance planning materially affect ownership outcomes for spectroscopy users.
Limited availability of trained spectroscopy expertise can restrict effective use in some laboratories, particularly where staff turnover is high. Interpreting spectra and applying consistent analysis frameworks requires technical experience and validated workflows. Organizations may require training programs and method standardization to reduce variability. Skill constraints can delay deployment and reduce throughput benefits in early adoption phases.
Circular Dichroism Spectrometers Market Trends and Opportunities
Automation and higher-throughput sampling are becoming more important as structural characterization becomes embedded into routine workflows. Laboratories increasingly seek configurations that support repeatable runs with minimal operator intervention and consistent processing. This trend supports opportunities for platforms with improved autosampling, stable performance, and workflow-ready software. Vendors that align instrument design with practical lab throughput requirements are better positioned for upgrade-driven sales.
For instance, JASCO’s HTCD Plus system, coupled with the ASU-800 autosampler and ASP-849 syringe pump on its J-1500/J-1700 platforms, enables fully automated CD measurement of up to 192 samples across two 96-well microplates without any human intervention, completing each sample run in approximately 3 minutes (45 seconds per scan across 4 accumulations).
Growing use of CD in emerging application niches creates incremental opportunity beyond conventional protein studies. Expansion of chiral compound analysis workflows and micro-scale measurement approaches increases the need for adaptable platform configurations. As research programs diversify, buyers prefer systems that can serve multiple use cases without major reconfiguration. This increases demand for flexible platforms and application support ecosystems.
Regional Insights
North America
North America represented 36.70% of the market in 2025. The region benefits from a mature biopharma ecosystem, strong academic research networks, and established analytical testing infrastructure. Adoption is supported by upgrade cycles among existing users seeking improved sensitivity and workflow efficiency. Demand also remains strong in outsourced analytical services supporting development programs and comparability needs.
Europe
Europe accounted for 22.90% share in 2025. The regional market is supported by a broad base of academic and research institutes and sustained pharmaceutical R&D activity. Laboratories emphasize reproducibility, documentation practices, and application support when selecting CD platforms. Public research funding and collaborations continue to support steady equipment modernization and utilization.
Asia Pacific
Asia Pacific held 29.40% share in 2025. Growth is supported by expanding biologics and biosimilars activity, increasing CRO/CMO capacity, and broader investments in analytical characterization tools. The region also benefits from an expanding base of biotech clusters and research infrastructure upgrades. Buyers prioritize flexibility and throughput to maximize instrument utilization across multiple programs.
Latin America
Latin America represented 6.10% share in 2025. Adoption is concentrated in leading research hubs and select pharmaceutical environments where specialized spectroscopy demand is justified. Shared facilities and centralized research centers play an important role in access to advanced CD systems. Procurement decisions are typically sensitive to total cost and service support availability.
Middle East & Africa
Middle East & Africa accounted for 4.90% share in 2025. The region remains smaller due to limited broad-based deployment of niche chiroptical tools, with activity concentrated in specific research and healthcare innovation centers. Expansion of research infrastructure and targeted investments in advanced analytics can gradually support demand. Availability of training and vendor service ecosystems remains an important adoption factor.
Competitive Landscape
Competition is shaped by instrument performance, application breadth, software usability, and service responsiveness. Vendors differentiate through configurable platforms that address routine protein characterization and specialized chiral workflows, supported by method guidance and application notes. After-sales service contracts and training programs play a significant role in retention and repeat purchases, especially where technical expertise constraints influence customer outcomes. Product positioning also reflects laboratory throughput needs, integration into existing analytical practices, and upgrade pathways for installed customers.
JASCO is commonly positioned around robust circular dichroism instrumentation capabilities and application-centric workflow support for protein structural studies and broader chiroptical measurement needs. The company’s approach typically emphasizes repeatable measurement quality, accessible training resources, and configuration options that match both academic and industrial laboratory requirements. This combination supports adoption in multi-user environments where method consistency and operator enablement influence utilization. Vendor-led community engagement and user-oriented programs reinforce long-term customer relationships.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In June 2025, CRAIC Technologies highlighted the introduction of Circular Dichroism Microspectroscopy to enable circular dichroism measurements on micron-scale samples. This development broadens potential use cases where sample volume or measurement footprint previously limited applicability.
In February 2026, JASCO announced a Circular Dichroism User Group event scheduled for April 2026. The initiative supports training and workflow adoption, which is important in a market where skilled operator availability can constrain utilization.
In January 2026, HORIBA Scientific announced a compact industrial spectrometer platform under its spectroscopy portfolio. Broader platform innovation in spectroscopy can support component and workflow advances relevant to specialized optical measurement systems.
Report Scope
Report Attribute
Details
Market size value in 2025
USD 38.27 million
Revenue forecast in 2032
USD 58 million
Growth rate (CAGR)
6.1% (2025–2032)
Base year
2025
Forecast period
2026–2032
Quantitative units
USD million
Segments covered
By Type Outlook: Benchtop, Portable; By Product Outlook: Linearly polarized light sources, Circularly polarized light sources, Multiple light sources; By Application Outlook: Protein Secondary Structure Analysis, Nucleic Acid Analysis, Pharmaceutical & Biopharmaceutical Research, Chiral Compound Analysis, Others; By End User Outlook: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Others
Regional scope
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Market Breakup by Region
10.1. North America
10.1.1. United States
10.1.1.1. Market Trends
10.1.1.2. Market Forecast
10.1.2. Canada
10.1.2.1. Market Trends
10.1.2.2. Market Forecast
10.2. Asia-Pacific
10.2.1. China
10.2.2. Japan
10.2.3. India
10.2.4. South Korea
10.2.5. Australia
10.2.6. Indonesia
10.2.7. Others
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. United Kingdom
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Others
10.4. Latin America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Others
10.5. Middle East and Africa
10.5.1. Market Trends
10.5.2. Market Breakup by Country
10.5.3. Market Forecast
Porters Five Forces Analysis
13.1. Overview
13.2. Bargaining Power of Buyers
13.3. Bargaining Power of Suppliers
13.4. Degree of Competition
13.5. Threat of New Entrants
13.6. Threat of Substitutes
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the market size of the Circular Dichroism Spectrometers Market in 2025 and its forecast for 2032?
The market was valued at USD 38.27 million in 2025 and is projected to reach USD 58 million by 2032. This growth reflects expanding structural characterization needs in biopharma and research labs.
What is the CAGR for the Circular Dichroism Spectrometers Market during 2025–2032?
The market is expected to grow at a 6.1% CAGR from 2025 to 2032. Demand is supported by biologics development and stability/comparability workflows.
Which segment is the largest in 2025?
Benchtop systems are the largest segment in 2025, with an adjusted share of 41.60%. The segment benefits from routine lab suitability and repeatable workflow performance.
What are the main factors driving market growth?
Key factors include biologics and biosimilars characterization needs, formulation screening demand, and workflow modernization. Outsourcing growth and expanding research infrastructure further support adoption.
Who are the leading companies in this market?
Leading companies include JASCO, Applied Photophysics, Bio-Logic Science Instruments, Hinds Instruments, Bruker, Thermo Fisher Scientific, Agilent Technologies, Shimadzu, CRAIC Technologies, and HORIBA Scientific. These companies compete through performance, workflow support, and service capabilities.
Which region leads the market in 2025?
North America leads the market in 2025 with an adjusted share of 36.70%. The region benefits from strong biopharma R&D, academic infrastructure, and established analytical testing capacity.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The global Clear Aligners Market size was estimated at USD 5,136 million in 2025 and is expected to reach USD 8,498 million by 2032, growing at a CAGR of 7.46% from 2025 to 2032.
The global CircRNA Synthesis Market size was estimated at USD 189.75 million in 2025 and is expected to reach USD 527 million by 2032, growing at a CAGR of 15.7% from 2025 to 2032,
The global Complex Injectables Market size was estimated at USD 26,141 million in 2025 and is expected to reach USD 46,572 million by 2032, growing at a CAGR of 8.6% from 2025 to 2032.
The global Chronic Venous Occlusions Treatment Market size was estimated at USD 7,419 million in 2025 and is expected to reach USD 9,942 million by 2032, growing at a CAGR of 4.27% from 2025 to 2032.
The global Chronic Kidney Disease Market size was estimated at USD 90,246 million in 2025 and is expected to reach USD 133,030 million by 2032, growing at a CAGR of 5.7% from 2025 to 2032.
The global Carglumic Acid Market size was estimated at USD 126.26 million in 2025 and is expected to reach USD 191 million by 2032, growing at a CAGR of 6.1% from 2025 to 2032.
The global Cardiovascular and Soft Tissue Repair Patches Market size was estimated at USD 5214 million in 2025 and is expected to reach USD 9053 million by 2032, growing at a CAGR of 8.2% from 2025 to 2032.
The global Cheek Augmentation Market size was estimated at USD 4709 million in 2025 and is expected to reach USD 8070 million by 2032, growing at a CAGR of 8% from 2025 to 2032.
The global Cardiovascular Drugs Market size was estimated at USD 157,413 million in 2025 and is expected to reach USD 212,787 million by 2032, growing at a CAGR of 4.4% from 2025 to 2032.
The global Cardiac Sutures Market size was estimated at USD 1,589 million in 2025 and is expected to reach USD 3,019 million by 2032, growing at a CAGR of 9.6% from 2025 to 2032.
The global Chromoendoscopy Agents Market size was estimated at USD 459.03 million in 2025 and is expected to reach USD 737 million by 2032, growing at a CAGR of 7% from 2025 to 2032.
The global Cholesterol Testing Products And Services Market size was estimated at USD 21,435 million in 2025 and is expected to reach USD 36,975 million by 2032, growing at a CAGR of 8.1% from 2025 to 2032.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$4999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
